Schedule 13D ownership disclosure
Clementia Pharmaceuticals Inc.
Security class unavailable · CUSIP: 185575107
Event date: 2019-02-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 32.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-19-000173
- Form type
- SC 13D
- Filer
- Clementia Pharmaceuticals Inc.
- CIK
- CIK 1647320
- Filed
- Mar 01, 2019
- Reporting period
- Feb 24, 2019
- Description
- Schedule 13D beneficial ownership